Results 251 to 260 of about 10,379,704 (316)

Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease. [PDF]

Sci Rep
Bradford BM, Walmsley-Rowe L, Reynolds J, Verity N, Mabbott NA.   +4 more
europepmc   +2 more sources

Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease. [PDF]

Biomolecules
Shimamura M, Weijie K, Nonaka T, Kosami K, Ae R, Fujita K, Matsubayashi T, Tsukamoto T, Sanjo N, Satoh K.   +9 more
europepmc   +1 more source

Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease. [PDF]

Acta Neuropathol
McDonough GA, Cheng Y, Morillo KS, Doan RN, Zhou Z, Kenny CJ, Foutz A, Kim C, Cohen ML, Appleby BS, Walsh CA, Safar JG, Huang AY, Miller MB.   +13 more
europepmc   +1 more source

Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion. [PDF]

Neurology
Vallabh SM, Mortberg MA, Allen SW, Kupferschmid AC, Kivisakk P, Hammerschlag BL, Bolling A, Trombetta BA, Devitte-McKee K, Ford AM, Sather LE, Duffy G, Rivera A, Gerber J, McManus AJ, Minikel EV, Arnold SE.   +16 more
europepmc   +1 more source

Molecular signatures in prion disease: altered death receptor pathways in a mouse model. [PDF]

J Transl Med
Giri RK.
europepmc   +1 more source

Expression of Toll-like receptors in the cerebellum during pathogenesis of prion disease. [PDF]

Front Behav Neurosci
Liao X, Zhu W, Liao X, Liu W, Hou Y, Wan J.   +5 more
europepmc   +1 more source

Prion protein E219K polymorphism: from the discovery of the KANNO blood group to interventions for human prion disease. [PDF]

Front Neurol
Wang SS, Meng ZL, Zhang YW, Yan YS, Li LB.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prion Disease

Seminars in Neurology, 2019
AbstractPrion diseases are a phenotypically diverse set of disorders characterized by protease-resistant abnormally shaped proteins known as prions. There are three main groups of prion diseases, termed sporadic (Creutzfeldt–Jakob disease [CJD], sporadic fatal insomnia, and variably protease-sensitive prionopathy), genetic (genetic CJD, fatal familial ...
Kelly J, Baldwin, Cynthia M, Correll
openaire   +3 more sources

Prion disease

Handbook of Clinical Neurology, 2018
Genetic prion diseases (gPrDs) are caused by autosomal-dominant mutations in the prion protein gene (PRNP). Although the first PRNP mutations identified, and most since, are PRNP missense, octapeptide repeat insertions, deletion and nonsense mutations have now also been shown to cause gPrD. Based on clinicopathologic features of familial disease, gPrDs
Leonel T, Takada, Mee-Ohk, Kim, Stacy, Metcalf, Ignacio Illán, Gala, Michael D, Geschwind   +4 more
openaire   +3 more sources